Bio Green Med Solution (BGMS) Non Operating Income (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Non Operating Income of $79000.0 for Q1 2026, up 887.5% year-over-year from $8000.0 in Q1 2025, and down 83.4% quarter-over-quarter from $476000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Non Operating Income (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Non Operating Income for 17 consecutive years, with $79000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 887.5% year-over-year to $79000.0; the TTM figure through Mar 2026 stood at $560000.0 (up 1613.51% YoY), while the FY2025 annual figure was $5.4 million, up 54260.0% from the prior year.
- Non Operating Income slipped to $79000.0 in Q1 2026 per BGMS's latest filing, from $476000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $1.3 million in Q1 2022 and bottomed at -$333000.0 in Q4 2023.
- Historically, Non Operating Income has averaged $130647.1 across 5 years, with a median of $10000.0 in 2024.
- On a YoY basis, Non Operating Income climbed as much as 2646.15% in 2022 and fell as far as 460.47% in 2022.
- Bio Green Med Solution's Non Operating Income stood at -$155000.0 in 2022, then slumped by 114.84% to -$333000.0 in 2023, then jumped by 90.99% to -$30000.0 in 2024, then surged by 1686.67% to $476000.0 in 2025, then tumbled by 83.4% to $79000.0 in 2026.
- Business Quant data shows BGMS's Non Operating Income at $79000.0 in Q1 2026, $476000.0 in Q4 2025, and $4000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.25 Bn | 133.40 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.50 Bn | 78.51 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.57 Bn | 52.43 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.65 Bn | 44.65 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 40.37 Bn | 35.27 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.40 Bn | 32.09 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.60 Bn | 26.44 Bn | 358.27 Mn | - |
| 10 | Bio Green Med Solution | 4.87 Mn | 1.08 Mn | 79,000.00 | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 476,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | -25,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | -333,000.00 |
| Sep 30, 2023 | 145,000.00 |
| Jun 30, 2023 | -105,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Dec 31, 2022 | -155,000.00 |
| Sep 30, 2022 | 357,000.00 |
| Jun 30, 2022 | 226,000.00 |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 43,000.00 |
| Sep 30, 2021 | 13,000.00 |